Inter-species and inter-individual differences in the hepatic levels and activities of drug-metabolizing enzymes (DME) result from genetic as well as from environmental factors and play a decisive role in determining the pharmacokinetic properties of a drug in a given test system. In vitro non-human cultures enable affordable testing of large compound libraries to prioritize lead compounds and allow for the selection an animal model with human-like responses.
